135 related articles for article (PubMed ID: 27878260)
21. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
[TBL] [Abstract][Full Text] [Related]
22. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
Jiang L; Huang J; Li L; Chen Y; Chen X; Zhao X; Yang D
J Clin Endocrinol Metab; 2015 May; 100(5):E729-38. PubMed ID: 25695884
[TBL] [Abstract][Full Text] [Related]
24. Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer.
Li X; Li J; Cai Y; Peng S; Wang J; Xiao Z; Wang Y; Tao Y; Li J; Leng Q; Wu D; Yang S; Ji Z; Han Y; Li L; Gao X; Zeng C; Wen X
Cancer Lett; 2018 Apr; 418():211-220. PubMed ID: 29331421
[TBL] [Abstract][Full Text] [Related]
25. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels.
Honeywell DR; Cabrita MA; Zhao H; Dimitroulakos J; Addison CL
PLoS One; 2013; 8(8):e70515. PubMed ID: 23950948
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1.
Lee KH; Lin FC; Hsu TI; Lin JT; Guo JH; Tsai CH; Lee YC; Lee YC; Chen CL; Hsiao M; Lu PJ
Biochim Biophys Acta; 2014 Sep; 1843(9):2055-66. PubMed ID: 24915000
[TBL] [Abstract][Full Text] [Related]
27. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling.
Zhang Z; Shao L; Wang Y; Luo X
Biochem Biophys Res Commun; 2019 Feb; 509(3):746-752. PubMed ID: 30621914
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
Shin SS; Park SS; Hwang B; Moon B; Kim WT; Kim WJ; Moon SK
Oncol Rep; 2016 Oct; 36(4):2313-20. PubMed ID: 27573859
[TBL] [Abstract][Full Text] [Related]
30. Effects of serum on (-)-gossypol-suppressed growth in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Sugimoto Y; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(5A):3613-20. PubMed ID: 17094491
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
32. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression.
Ozen M; Karatas OF; Gulluoglu S; Bayrak OF; Sevli S; Guzel E; Ekici ID; Caskurlu T; Solak M; Creighton CJ; Ittmann M
Cancer Invest; 2015 Jul; 33(6):251-8. PubMed ID: 25951106
[TBL] [Abstract][Full Text] [Related]
34. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
35. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
36. The Regulatory Effects of CDKN1A on Relevant Genes in Kaposi's Sarcoma Cells.
Zhang J; Pu XM; Wu XJ
Ann Clin Lab Sci; 2019 Sep; 49(5):568-573. PubMed ID: 31611198
[TBL] [Abstract][Full Text] [Related]
37. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.
Tan G; Jiang L; Li G; Bai K
Technol Cancer Res Treat; 2020; 19():1533033820948062. PubMed ID: 33063634
[TBL] [Abstract][Full Text] [Related]
38. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-26a inhibits multiple myeloma cell growth by suppressing cyclin-dependent kinase 6 expression.
Xu YY; Song YQ; Huang ZM; Zhang HB; Chen M
Kaohsiung J Med Sci; 2019 May; 35(5):277-283. PubMed ID: 30897301
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
